- Home
- PAPL vs XXII Comparison
PAPL vs XXII Comparison
Compare PAPL & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAPL
- XXII
- Stock Information
- Founded
- PAPL 2015
- XXII 1998
- Country
- PAPL Canada
- XXII United States
- Employees
- PAPL N/A
- XXII N/A
- Industry
- PAPL Finance: Consumer Services
- XXII Medicinal Chemicals and Botanical Products
- Sector
- PAPL Finance
- XXII Health Care
- Exchange
- PAPL Nasdaq
- XXII Nasdaq
- Market Cap
- PAPL 2.5M
- XXII 2.1M
- IPO Year
- PAPL 2023
- XXII N/A
- Fundamental
- Price
- PAPL $0.29
- XXII $0.78
- Analyst Decision
- PAPL Strong Buy
- XXII
- Analyst Count
- PAPL 2
- XXII 0
- Target Price
- PAPL $5.25
- XXII N/A
- AVG Volume (30 Days)
- PAPL 54.5K
- XXII 1.6M
- Earning Date
- PAPL 04-14-2025
- XXII 05-14-2025
- Dividend Yield
- PAPL N/A
- XXII N/A
- EPS Growth
- PAPL N/A
- XXII N/A
- EPS
- PAPL N/A
- XXII N/A
- Revenue
- PAPL $2,848,365.00
- XXII $24,382,000.00
- Revenue This Year
- PAPL $22.95
- XXII $19.23
- Revenue Next Year
- PAPL $29.98
- XXII $81.05
- P/E Ratio
- PAPL N/A
- XXII N/A
- Revenue Growth
- PAPL 13.01
- XXII N/A
- 52 Week Low
- PAPL $0.18
- XXII $0.70
- 52 Week High
- PAPL $2.14
- XXII $265.95
- Technical
- Relative Strength Index (RSI)
- PAPL 43.64
- XXII 22.31
- Support Level
- PAPL $0.25
- XXII $0.70
- Resistance Level
- PAPL $0.31
- XXII $0.91
- Average True Range (ATR)
- PAPL 0.03
- XXII 0.25
- MACD
- PAPL 0.00
- XXII 0.02
- Stochastic Oscillator
- PAPL 52.78
- XXII 4.31
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.